Portfolio Manager Factsheet

August 2017

Investor concerns over a poor second quarter report from Wright Medical proved unfounded as the company reported better than expected revenues and earnings. Mylan’s second quarter results were below market expectations as the generic drug pricing in the U.S. has deteriorated, adversely affecting Mylans’ reported revenues and margins, while delays to new product launches exacerbated the situation.  

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.